« Back
Home /
NXY-059

NXY-059

Item no.	M1868-200mg
Manufacturer	AbMole
CASRN	168021-79-2
Amount	200mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lymphatic System Cancer
Type	Inhibitors
Specific against	other
Purity	>98%
Citations	Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study. Culot, et al . Brain Res. 2009 Oct 19,1294:144-52. PMID: 19631615 . Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. Bath, et al . Br J Pharmacol. 2009 Aug,157(7):1157-71. PMID: 19422398 . The nitrone free radical scavenger NXY-059 is neuroprotective when administered after traumatic brain injury in the rat. Clausen, et al . J Neurotrauma. 2008 Dec,25(12):1449-57. PMID: 19118455 .
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Disufenton sodium, Cerovive
Similar products	NXY-059, Disufenton sodium, Cerovive
Available
Target Information	Others
Molecular Weight	381, 33
Solubility	DMSO ≥60 mg/mL; Water ≥60 mg/mL
Bioactivity information	NXY-059 is a free radical-trapping neuroprotectant that has been reported to reduce infarct size and preserve brain function in experimental models of acute ischemic stroke.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1868-200mg-safety-datasheet.pdf